Evaluation of Positive Inotropic Drug Effects on Thyroid Hormone Levels after Open Heart Surgery
Objective: The aim of this study was to examine the effects of positive inotropic drugs, including adrenaline, dopamine, and dobutamine on thyroid hormone levels following open heart surgery.
Methods: We analyzed free thyroid hormones (FT3 and FT4) and thyroid-stimulating hormones (TSH) in 200 consecutive patients undergoing open heart surgery. Patients were divided into 5 groups according to the inotropic drug administration as follows: Group A (n = 46) received dopamine alone; Group B (n = 40), dopamine and dobutamine; Group C (n = 36), dopamine, dobutamine, and adrenaline; Group D (n = 32), adrenaline alone; and Group E (n = 46), placebo. Procedural factors affecting thyroid hormones were recorded and included cardiopulmonary bypass (CPB) time, cross-clamping time, degree of hypothermia, and the duration and doses of positive inotropic drugs. Blood samples for hormone assays were collected before initiation of inotropic drug therapy (baseline) and postoperatively at 24, 72, and 120 hours after drug therapy.
Results: FT3, FT4, and TSH levels at baseline were similar in all groups. Although there was a trend showing very slight increases in thyroid hormone levels from baseline to the 24th, 72nd, and 120th postoperative hours after drug therapy, these changes were not significant, and there were also no significant differences between the groups. There was also no significant statistical difference in CPB time, cross-clamping time, degree of hypothermia, and duration and doses of positive inotropic drugs between groups.
Conclusion: Although thyroid hormone levels were affected by positive inotropic drug usage after open heart surgery, this effect was not significant and thyroid hormone levels remained within normal ranges.
Afandi B, Schussler GC, Arafeh AH, Boutros A, Yap MG, Finkelstein A. 2000. Selective consumption of thyroxine-binding globulin during cardiac bypass surgery. Metabolism 49:270-4.nBennett-Guerrero E, Jimenez JL, White WD, D'Amico EB, Baldwin BI, Schwin DA. 1996. Cardiovascular effects of intravenous triiodothyronine in patients undergoing coronary artery bypass graft surgery. A randomized, double-blind, placebo-controlled trial. Duke T3 study group. JAMA 275:687-92.nBettendorf M, Schmidt KG, Tiefenbacher U, Grulich-Henn J, Heinrich UE, Schönberg DK. 1997. Transient secondary hypothyroidism in children after cardiac surgery. Pediatr Res 41:375-9.nButtrick P, Malhotra A, Factor S, Geenen D, Scheuer J. 1988. Effects of chronic dobutamine administration on hearts of normal and hypertensive rats. Circ Res 63:173-81.nCerillo AG, Storti S, Mariani M, et al. 2005. The non-thyroidal illness syndrome after coronary artery bypass grafting: a 6-month follow-up study. Clin Chem Lab Med 43:289-93.nCoiro V, Volpi R, Cataldo S, et al. 2000. Dopaminergic and cholinergic involvement in the inhibitory effect of dexamethasone on the TSH response to TRH. J Investig Med 48:133-6.nDe Groot LJ. 1999. Dangerous dogmas in medicine: the nonthyroidal illness syndrome. J Clin Endocrinol Metab 84:151-64.nEggum R, Ueland T, Mollnes TE, et al. 2010. Perfusion temperature, thyroid hormones and inflammation during pediatric cardiac surgery. Interact Cardiovasc Thorac Surg 10:76-80.nHeinen E, Herrmann J, Lippe J, Dudek M, Krüskemper HL. 1983. Effect of dopamine and dobutamine on thyroid hormone concentration [in German]. Med Welt 34:696-9.nHolland FW 2nd, Brown PS Jr, Weintraub BD, Clark RE. 1991. Cardiopulmonary bypass and thyroid function: a "euthyroid sick syndrome." Ann Thorac Surg 52:46-50.nLee E, Chen P, Rao H, Lee J, Burmeister LA. 1999. Effect of acute high dose dobutamine administration on serum thyrotrophin (TSH). Clin Endocrinol (Oxf) 50:487-92.nMitchell IM, Pollock JC, Jamieson MP, Donaghey SF, Paton RD, Logan RW. 1992. The effects of cardiopulmonary bypass on thyroid function in infants weighing less than five kilograms. J Thorac Cardiovasc Surg 103:800-5.nReinhardt W, Mocker V, Jockenhövel F, et al. 1997. Influence of coronary artery bypass surgery on thyroid hormone parameters. Horm Res 47:1-8.nRoth-Härer A, Lilienthal H, Bubser M, et al. 2001. Neurotransmitter concentrations and binding at dopamine receptors in rats after maternal exposure to 3,4,3,4-tetrachlorobiphenyl: the role of reduced thyroid hormone concentrations. Environ Toxicol Pharmacol 9:103-15.nSaatvedt K, Lindberg H, Geiran OR, et al. 1998. Thyroid function during and after cardiopulmonary bypass in children. Acta Anaesthesiol Scand 42:1100-3.nThrush DN, Austin D, Burdash N. 1995. Cardiopulmonary bypass temperature does not affect postoperative euthyroid sick syndrome? Chest 108:1541-5.nVan den Berghe G, de Zegher F, Lauwers P. 1994. Dopamine and the sick euthyroid syndrome in critical illness. Clin Endocrinol (Oxf) 41:731-7.nVan den Berghe G, de Zegher F. 1996. Anterior pituitary function during critical illness and dopamine treatment. Crit Care Med 24:1580-90.nVander Salm TJ, Stahl RS. Early postoperative care. In: Edmunds LH, ed. Cardiac surgery in the adult. 1st ed. Philadelphia: The McGraw-Hill Companies; 1997: 339-67.nVelissaris T, Tang AT, Wood PJ, Hett DA, Ohri S.K 2009. Thyroid function during coronary surgery with and without cardiopulmonary bypass. Eur J Cardiothorac Surg 36:148-54.n
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).